XML 29 R21.htm IDEA: XBRL DOCUMENT
v3.25.2

Fair Value Measurements (Tables) | 6 Months Ended
--- | ---
Aug. 02, 2025
Fair Value Disclosures [Abstract] |
Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis | The following table presents financial instruments that are measured at fair value on a recurring basis at August 2, 2025, February 1, 2025 and August 3, 2024:
|  | Fair Value Measurements |
(In thousands) |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
As of August 2, 2025 |  |  |  |  |  |  |  |  |  |  |  |
Cash equivalents - money market mutual funds |  | $ | 53,882 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 53,882 |
Marketable securities - mutual funds that fund deferred compensation |  |  | 13,198 |  |  |  | 0 |  |  |  | 0 |  |  |  | 13,198 |
Total |  | $ | 67,080 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 67,080 |
As of February 1, 2025 |  |  |  |  |  |  |  |  |  |  |  |
Cash equivalents - money market mutual funds |  | $ | 95,963 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 95,963 |
Marketable securities - mutual funds that fund deferred compensation |  |  | 14,432 |  |  |  | 0 |  |  |  | 0 |  |  |  | 14,432 |
Total |  | $ | 110,395 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 110,395 |
As of August 3, 2024 |  |  |  |  |  |  |  |  |  |  |  |
Cash equivalents - money market mutual funds |  | $ | 44,072 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 44,072 |
Marketable securities - mutual funds that fund deferred compensation |  |  | 12,831 |  |  |  | 0 |  |  |  | 0 |  |  |  | 12,831 |
Total |  | $ | 56,903 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 56,903 |
Schedule of Liabilities Measure at Fair Value on Recurring Basis | The following table presents liabilities that are measured at fair value on a recurring basis at August 2, 2025, February 1, 2025 and August 3, 2024:
|  | Fair Value Measurements |
(In thousands) |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
As of August 2, 2025 |  |  |  |  |  |  |  |  |  |  |  |
Contingent consideration |  | $ | 0 |  |  | $ | 0 |  |  | $ | 406 |  |  | $ | 406 |
Total |  | $ | 0 |  |  | $ | 0 |  |  | $ | 406 |  |  | $ | 406 |
As of February 1, 2025 |  |  |  |  |  |  |  |  |  |  |  |
Contingent consideration |  | $ | 0 |  |  | $ | 0 |  |  | $ | 395 |  |  | $ | 395 |
Total |  | $ | 0 |  |  | $ | 0 |  |  | $ | 395 |  |  | $ | 395 |
As of August 3, 2024 |  |  |  |  |  |  |  |  |  |  |  |
Contingent consideration |  | $ | 0 |  |  | $ | 0 |  |  | $ | 3,728 |  |  | $ | 3,728 |
Total |  | $ | 0 |  |  | $ | 0 |  |  | $ | 3,728 |  |  | $ | 3,728 |
Schedule Of Deferred Compensation Plan Liabilities And Related Marketable Securities | The following tables present the balances and activity of the Company’s deferred compensation plan liabilities and related Marketable Securities:
(In thousands) |  | August 2, 2025 |  |  | February 1, 2025 |  |  | August 3, 2024 |
Deferred compensation plan current liabilities |  | $ | 2,510 |  |  | $ | 4,259 |  |  | $ | 193 |
Deferred compensation plan long-term liabilities |  |  | 10,243 |  |  |  | 10,011 |  |  |  | 12,564 |
Total deferred compensation plan liabilities |  | $ | 12,753 |  |  | $ | 14,270 |  |  | $ | 12,757 |
Marketable securities - mutual funds that fund deferred compensation |  | $ | 13,198 |  |  | $ | 14,432 |  |  | $ | 12,831 |
(In thousands) |  | Thirteen Weeks Ended August 2, 2025 |  |  | Thirteen Weeks Ended August 3, 2024 |  |  | Twenty-six Weeks Ended August 2, 2025 |  |  | Twenty-six Weeks Ended August 3, 2024 |
Deferred compensation liabilities |  |  |  |  |  |  |  |  |  |  |  |
Employer contributions, net |  | $ | 65 |  |  | $ | 71 |  |  | $ | 179 |  |  | $ | 152 |
Investment earnings |  |  | 724 |  |  |  | 259 |  |  |  | 288 |  |  |  | 582 |
Marketable Securities |  |  |  |  |  |  |  |  |  |  |  |
Mark-to-market gains (1) |  |  | (891 | ) |  |  | (276 | ) |  |  | (286 | ) |  |  | (584 | )
Net deferred compensation (income) expense |  | $ | (102 | ) |  | $ | 54 |  |  | $ | 181 |  |  | $ | 150 |
(1) Included in the mark-to-market activity related to equity securities still held at quarter-end, we recognized unrealized gains of $903,000 and $258,000 for the thirteen weeks ended August 2, 2025 and August 3, 2024, respectively, and unrealized gains of $809,000 and $550,000 for the twenty-six weeks ended August 2, 2025 and August 3, 2024, respectively.

X
- Definition Schedule of defered compensation plan liabilities and related marketable securities text block. + References No definition available. + Details
Name: | scvl_ScheduleOfDeferedCompensationPlanLiabilitiesAndRelatedMarketableSecuritiesTableTextBlock
Namespace Prefix: | scvl_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration